The DOI matches its Crossref record.
Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM
Abstract
OBJECTIVE: Serum gamma-glutamyltransferase (GGT) levels are raised in obese individuals, and a particularly strong association with central obesity has been described. We hypothesized that elevated GGT levels are a marker for visceral fat, and specifically for hepatic steatosis (fatty liver), and that hepatic steatosis leads to hepatic insulin resistance. To test this hypothesis, we examined the association between GGT levels and risk of NIDDM. RESEARCH DESIGN AND METHODS: We carried out a prospective cohort study of incident cases of doctor-diagnosed NIDDM in a group of 7,458 nondiabetic men (aged 40-59 years) followed for a mean of 12.8 years (range 11.5-13.0). The men were randomly selected from general practice lists in 24 British towns. Cases of NIDDM were ascertained by repeated postal questionnaires to the men and by regular systematic review of primary care records. RESULTS: A total of 194 men developed NIDDM during follow-up. Mean serum GGT at baseline (geometric mean [95% CI]) was significantly higher in the NIDDM patients than in the rest of the cohort (20.9 [19.3-22.6] vs. 15.3 U/l [15.0-15.6], P < 0.0001). There was a smooth, graded increase in the age-adjusted risk of NIDDM with increasing GGT levels, with a relative risk in the top fifth of the distribution of 6.8 (3.5-12.9) relative to the bottom fifth (trend P < 0.0001). This association was independent of serum glucose and BMI and of other predictors of NIDDM with which GGT is associated, including alcohol intake and physical activity level (adjusted upper to lower fifth relative risk: 4.8 [2.0-11.8], trend P < 0.0001]). CONCLUSIONS: These findings suggest that a raised serum GGT level is an independent risk factor for NIDDM. Serum GGT level may be a simple and reliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N onalcoholic fatty liver disease (NAFLD) precedes and predicts type 2 diabetes.[1][2][3][4][5][6]”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [3]
Citations
Cited by
Sorted by citations
Items 101–200 of 321
Simão, A. N. C., Dichi, J. B., Barbosa, D. S., Cecchini, R., & Dichi, I. (2008) · Nutrition · doi:10.1016/j.nut.2008.03.021 · Cited by 63
Lonardo, A., & Trande, P. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02226.x · Cited by 61
Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease
Sookoian, S. C., Castaño, G. O., Gianotti, T. F., Gemma, C., & Pirola, C. J. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.07.005 · Cited by 62
“On the contrary, we stratified and selected for biopsy those patients who showed a combination of abnormal liver function tests, which have been previously shown to be strongly associated with disease severity and its complications [28–30].”
MethodEzhumalai, M., Radhiga, T., & Pugalendi, K. V. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1810-8 · Cited by 61
“[44] have reported that high level of hepatic enzyme, GGT, is associated with later development of diabetes.”
BackgroundSridhar, S. B., Xu, F., Darbinian, J., Quesenberry, C. P., Ferrara, A., & Hedderson, M. M. (2014) · Diabetes Care · doi:10.2337/dc13-2229 · Cited by 59
Charles, M.-A. A., Eschw�ge, E., Grandmottet, P., Isnard, F., Cohen, J., Bensoussan, J.-L., Berche, H., Chapiro, O., Andr�, P., Vague, P., et al. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(200001/02)16:1 · Cited by 58
Croci, I., Coombes, J. S., Sandbakk, S. B., Keating, S. E., Nauman, J., Macdonald, G. A., & Wisløff, U. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.01.005 · Cited by 62
Ortega, E., Koška, J., Salbe, A. D., Tataranni, P. A., & Bunt, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1783 · Cited by 58
Buijsse, B., Feskens, E. J. M., Moschandreas, J. A., Jansen, E. H. J. M., Jacobs, D. R., Kafatos, A., Kok, F. J., & Kromhout, D. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280111e41 · Cited by 55
γ-Glutamyltransferase predicts cardiovascular death among Japanese women
Hozawa, A., Okamura, T., Kadowaki, T., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.058 · Cited by 56
Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease
Sookoian, S. C., Castaño, G. O., Gianotti, T. F., Gemma, C., Rosselli, M. S., & Pirola, C. J. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.001 · Cited by 54
Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat
Wallace, T. M., Utzschneider, K. M., Tong, J., Carr, D. B., Zraika, S., Bankson, D. D., Knopp, R. H., & Kahn, S. E. (2007) · Diabetes Care · doi:10.2337/dc06-1758 · Cited by 53
Yu, Z., Ley, S. H., Sun, Q., Hu, F. B., & Malik, V. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003841 · Cited by 56
γ-Glutamyltransferase is a promising biomarker for cardiovascular risk
Turgut, O. O., Yilmaz, A., Yalta, K., et al. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.010 · Cited by 53
Serum gamma-glutamyl transferase level and diabetes mellitus among US adults
Sabanayagam, C., Shankar, A., Li, J., Pollard, C. R., & DUCATMAN, A. M. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9346-7 · Cited by 51
“Several prospective [5–10] and cross-sectional studies [11–13] have reported a positive association between serum GGT and diabetes mellitus.”
BackgroundResultInsulin Resistance and Insulin-Like Growth Factors in Children with Intrauterine Growth Retardation
Cianfarani, S., Geremia, C., Germani, D., Scirè, G., Maiorana, A., & Boemi, S. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063455 · Cited by 52
“and it is noteworthy that raised γ-GT levels have recently been proposed as an independent risk factor for NIDDM [”
BackgroundSeebacher, V., Polterauer, S., Grimm, C., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.16 · Cited by 51
“Previous studies described that patients with elevated GGT were found to have elevated risk of diabetes (Perry et al, 1998).”
BackgroundJo, S.-K., Lee, W., Rhee, E., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.035 · Cited by 50
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 49
Coffee consumption, serum γ-glutamyltransferase and risk of type II diabetes
Bidel, S., Silventoinen, K., Hu, G., Lee, D., Kaprio, J. A., & Tuomilehto, J. O. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602712 · Cited by 55
Iwamoto, N., Ogawa, Y., Kajihara, S., et al. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00633-7 · Cited by 50
What does serum γ-glutamyltransferase tell us as a cardiometabolic risk marker?
Bulusu, S., & Sharma, M. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215597010 · Cited by 48
Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese
Cheung, B. M. Y., Ong, K. L., Tso, A. W. K., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.030 · Cited by 46
“Indeed, plasma GGT has also been reported to be predictive of incident diabetes [8,37,38] and the close relationship between raised blood pressure and dysglycemia in our population may also contribute to the association of plasma GGT with hypertension [21].”
BackgroundSerum γ-Glutamyltransferase and Risk of Disease
Whitfield, J. B. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.080911 · Cited by 46
Yamamoto, S., Watanabe, B., Hiratake, J., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183004 · Cited by 44
Tan, P. C., Aziz, A. Z., Ismail, I. S., & Omar, S. Z. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.05.025 · Cited by 43
Biochemical clinical factors associated with missed abortion independent of maternal age
Fang, J., Xie, B., Chen, B., et al. (2018) · Medicine · doi:10.1097/md.0000000000013573 · Cited by 43
Liu, X., Hamnvik, O. R., Chamberland, J. P., Petrou, M., Gong, H., Christophi, C. A., Christiani, D. C., Kales, S. N., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.008 · Cited by 41
“Several prospective studies have also shown that high levels of ALT and GGT are independently associatedwith increased risk for incidentmetabolic syndrome and diabetes [12,15–19].”
Liver function tests in type 2 Sudanese diabetic patients
Idris, A. S. O., Mekky, K. F. H., Abdalla, B. E., et al. (2011) · International Journal of Nutrition and Metabolism · doi:10.5897/ijnam.9000023 · Cited by 41
for the DESIR Study Group, Gautier, A., Balkau, B., Lange, C., Tichet, J., & Bonnet, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1602-6 · Cited by 39
“Recent prospective studies have confirmed a significant association between GGT activity and the incidence of type 2 diabetes in both sexes and in various populations, including the DESIR cohort [12–18].”
Conen, D., Vollenweider, P., Rousson, V., Marques-Vidal, P. M., Paccaud, F. M., Waeber, G., & Bochud, M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq308 · Cited by 38
Kim, S. G., Kim, H. Y., Seo, J. A., Lee, K. W., Oh, J. H., Kim, N. H., Choi, K. M., Baik, S. H., & Choi, D. S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01842 · Cited by 38
“Recently, several prospective studies have shown that elevated ALT and GGT are predictors of the development of type 2 diabetes ( 32 , 33), and it was reported that low serum adiponectin levels predict the development of type 2 diabetes and metabolic syndrome (34, 35).”
BackgroundAli, S. S., Oni, E., Blaha, M. J., Veledar, E., Feiz, H. R., Feldman, T., Agatston, A. S., Blumenthal, R. S., Conceição, R., Carvalho, J. A. M., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0097-7 · Cited by 37
Sugiura, M., Nakamura, M., Ikoma, Y., Yano, M., Ogawa, K., Matsumoto, H., Kato, M., Ohshima, M., & Nagao, A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.05.004 · Cited by 37
“Recently, a number of studies have suggested that abnormal hepatocellular function is associated with obesity, insulin resistance, and type 2 diabetes [12–16].”
BackgroundTokita, Y., Maejima, Y., Shimomura, K., Takenoshita, S., Ishiyama, N., Akuzawa, M., Shimomura, Y., & Nakajima, K. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7115 · Cited by 37
“The increased prevalence of NAFLD in relation to the development of diabetes has been reported in a cross-sectional study (16), and a close relationship between liver enzymes and diabetes has been reported in cohort studies (17-22).”
BackgroundGastrointestinal Complications of Diabetes Mellitus
Ebert, E. C. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.11.002 · Cited by 33
A Strong Secular Trend in Serum Gamma-Glutamyltransferase from 1996 to 2003 among South Korean Men
Lee, D., Ha, M.-H., Kam, S., Chun, B., Lee, J., Song, K., Boo, Y. C., Steffen, L. M., & Jacobs, D. R. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwj006 · Cited by 34
Study of life style habits on risk of type 2 diabetes
Pathak, A., & Pathak, R. (2012) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.106349 · Cited by 34
Association between gamma-glutamyltransferase and coronary artery calcification
Atar, A., Yılmaz, Ö. Ç., Akın, K., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.157 · Cited by 34
Tohidi, M., Harati, H., Hadaegh, F., et al. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-5 · Cited by 34
“vated in asymptomatic patients with NAFLD [5,6], the prospective association between the hepatic markers and type 2 diabetes is expected, as has been reported in many longitudinal studies [7-12].”
ResultTambascia, M. A., Geloneze, B., Repetto, E. M., Geloneze, S. R., Picolo, M., & Magro, D. O. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00285.x · Cited by 34
Sakugawa, H., Nakayoshi, T., Kobashigawa, K., et al. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i7.1052 · Cited by 34
Hayashi, J., Hasegawa, A., Hayashi, K., Suzuki, T., Ishii, M., Otsuka, H., Yatabe, K., Goto, S., Tatsumi, J., & Shin, K. (2017) · BMC Oral Health · doi:10.1186/s12903-017-0369-2 · Cited by 34
Relationship between γ-glutamyltransferase, lipids and lipoprotein(a) in the general population
Lippi, G., Targher, G., Montagnana, M., et al. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.06.005 · Cited by 32
Kim, N. H., Huh, J. K., Kim, B. J., et al. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.665539 · Cited by 31
Duman, B. S., Öztürk, M., Yılmazer, S., & Hatemi, H. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.201.147 · Cited by 30
“The relationship between GGT activities and its pro-oxidant effect has been demonstrated in vitro(Drozdz et al.1998;Enoiu et al.2000)and in clinical studies by the increase in lipid peroxidation(Pompela 1997;Perry et al.1998).”
BackgroundYasui, K., Harano, Y., Mitsuyoshi, H., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0133-8 · Cited by 30
Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans
Onur, S., Niklowitz, P., Jacobs, G., Nöthlings, U., Lieb, W., Menke, T., & Döring, F. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-427 · Cited by 29
“However, it has recently been shown that serum GGT is also a marker for the development of cardiovascular disease, hypertension, stroke and type 2 diabetes mellitus and their complications independent from alcohol consumption [19-22].”
BackgroundIs liver disease a threat to patients with metabolic disorders?
Marchesini, G., Forlani, G., & Bugianesi, E. (2005) · Annals of Medicine · doi:10.1080/07853890510011445 · Cited by 28
Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity
Beulens, J. W. J., van den Berg, R., Kok, F. J., Helander, A., Vermunt, S. H. F., & Hendriks, H. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.07.002 · Cited by 28
.GAMMA.-Glutamyl Transferase and Metabolic Risk Factors for Cardiovascular Disease
Sakuta, H., Suzuki, T., Yasuda, H., et al. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.538 · Cited by 28
Pathogenesis, Risk Assessment and Prevention of Type 2 Diabetes mellitus
Joost, H. (2008) · Obesity Facts · doi:10.1159/000137673 · Cited by 27
Parés, A. R., Tresserras, R., Núñez, I., Cerralbo, M., Plana, P., Pujol, F.-J., Massip, J., Caballería, L., Brú, C., Caballería, J., et al. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71364-9 · Cited by 26
Sillanaukee, P. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.339 · Cited by 26
Gamma-Glutamyl Transferase Levels in Patients with Acute Ischemic Stroke
Gurbuzer, N., Gözke, E., & Basturk, Z. A. (2014) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2014/170626 · Cited by 25
Zhao, W., Tong, J., Liu, J., Jin, L., Li, J., & Cao, Y. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5356498 · Cited by 24
Metabolic Syndrome, Gamma-Glutamyl Transferase, and Risk of Sudden Cardiac Death
Kim, Y. G., Han, K., Jeong, J. H., Roh, S., Choi, Y. Y., Min, K., Shim, J., Choi, J., & Kim, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071781 · Cited by 24
Elevated Serum Gamma-Glutamyltransferase Is a Strong Marker of Insulin Resistance in Obese Children
Lee, S. Y., Sung, E., & Chang, Y. (2013) · International Journal of Endocrinology · doi:10.1155/2013/578693 · Cited by 24
C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population
Wen, J., Liang, Y., Wang, F., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.11.002 · Cited by 24
Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome
Bozbaş, H. (2011) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2011.01205 · Cited by 24
Yılmaz, M. İ., Turgut, F. H., Kanbay, M., Sağlam, M., Sönmez, A., Yaman, H., Demirbaş, Ş., Ünal, H. U., Gök, M., Karaman, M., et al. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0354-2 · Cited by 24
“However, increasing number of prospective studies shows that serum GGT activity directly relates to an increased risk of death, major vascular and nonvascular outcomes, hypertension and diabetes, even after adjustment for alcohol consumption and established risk factors [11–20].”
BackgroundLi, M., Campbell, S., & McDermott, R. A. (2009) · Obesity · doi:10.1038/oby.2008.617 · Cited by 23
Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey
Mazidi, M., Katsiki, N., Mikhailidis, D. P., & Banach, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.012 · Cited by 23
Higashikawa, A., Suwazono, Y., Okubo, Y., Uetani, M., Kobayashi, E., Kido, T., & Nogawa, K. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.027 · Cited by 22
Probable NAFLD, by ALT levels, and diabetes among Filipino-American Women
Wong, C. A., Araneta, M. R. G., Barrett-Connor, E. L., Alcaraz, J. E., Castañeda, D. M., & Macera, C. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.012 · Cited by 22
“increasing levels of VAT, and are consistent with previous findings [37,38].”
BackgroundResultTanaka, N., Nagaya, T., Komatsu, M., Horiuchi, A., Tsuruta, G., Shirakawa, H., Umemura, T., Ichijo, T., Matsumoto, A., Yoshizawa, K., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01737.x · Cited by 20
Çelik, Ö., Çakmak, H. A., Satılmış, S., et al. (2014) · Clinical Cardiology · doi:10.1002/clc.22307 · Cited by 21
Gray, B. R., Mühlhäusler, B. S., Davies, P. S. W., et al. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.019 · Cited by 21
Jimba, S., Nakagami, T., Oya, J., et al. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0082 · Cited by 21
Glucose intolerance and serum aminotransferase activities in Japanese men
Miyake, Y., Eguchi, H., Shinchi, K., Oda, T., Sasazuki, S., & Kono, S. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00323-9 · Cited by 21
Haghighi, S., Amini, M., Pournaghshband, Z., et al. (2011) · PubMed · Cited by 21
Fatness, fitness, and cardiometabolic risk factors in middle-aged white men
O’Donovan, G., Kearney, E. M., Sherwood, R. A., & Hillsdon, M. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.009 · Cited by 20
“Therefore, we assessed traditional [5] and novel [6,7] cardiometabolic risk factors in the present study, including adipokines [7], markers of inflammation [6-9], and markers of liver damage [10-12].”
MethodTamura, K., Hayashi, N., George, J., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00439.2015 · Cited by 20
Zhang, F., Liu, T., Gao, P., et al. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/7671508 · Cited by 20
Völzke, H., Alte, D., Ittermann, T., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02371.x · Cited by 20
Wolffenbuttel, B. H. R., Sels, J.-P. J. E., & Huijberts, M. S. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.3.467 · Cited by 20
“Elevated serum γ-glutaryl transferase (GGT) levels may be an independent risk factor for Type 2 diabetes [39].”
BackgroundAssociation between liver enzymes and type 2 diabetes: a real-world study
Bi, Y., Yang, Y., Yuan, X., Wang, J., Wang, T., Liu, Z., Tian, S., & Sun, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1340604 · Cited by 24
Prevalence of obesity and associated risk factors in Northeastern China
Shi, X. D., He, S., Tao, Y., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.002 · Cited by 19
Laspa, E., Christen, A., Efstathiadou, Z. A., Johnston, D. G., & Godsland, I. F. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02225.x · Cited by 20
Arasteh, S., Moohebati, M., Avan, A., et al. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.11.017 · Cited by 19
Ehehalt, F., Sturm, D., Rösler, M., Distler, M., Weitz, J., Kersting, S., Ludwig, B., Schwanebeck, U., Saeger, H., Solimena, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134140 · Cited by 21
The associations between height components (leg and trunk length) and adult levels of liver enzymes
Fraser, A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.053181 · Cited by 18
Hong, N. S., Kim, J.-G., Lee, Y., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-57 · Cited by 18
“Background Serum γ-glutamyltransferase (GGT) within the normal range has emerged as an important predictor of type 2 diabetes (T2D) among various populations [1-5].”
BackgroundYoshimura, E., Kumahara, H., Tobina, T., Ayabe, M., Matono, S., Anzai, K., Higaki, Y., Kiyonaga, A., & Tanaka, H. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.03.003 · Cited by 18
Gao, F., Pan, J., Hou, X. H., et al. (2012) · PubMed · doi:10.3967/0895-3988.2012.01.005 · Cited by 18
Coffee consumption and type 2 diabetes — An extensive review
Bidel, S., Hu, G., & Tuomilehto, J. O. (2007) · Open Medicine · doi:10.2478/s11536-007-0059-6 · Cited by 18
Chen, T., Ren, Y., Liu, Y., Long, Y., Zhang, X., Yu, H., Xu, J. R., Yu, T., & Tian, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.017 · Cited by 15
“Accumulating evidence of epidemiologic studies demonstrated that elevated gamma-glutamyl transferase (GGT) [1–3], and ferritin level [4–9] could both increase the risk of type 2 diabetes (T2D).”
BackgroundHozawa, A., Okamura, T., Tanaka, T., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3202 · Cited by 17
Takase, M., Nakaya, N., Tanno, K., Kogure, M., Hatanaka, R., Nakaya, K., Chiba, I., Kanno, I., Nochioka, K., Tsuchiya, N., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01582-1 · Cited by 18
Serum Gamma - Glutamyltransferase Is Associated with Albuminuria: A Population-Based Study
Sun, K., Li, F., Lin, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114970 · Cited by 16
Edlinger, M., Concin, N., Concin, H., et al. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2012.12.003 · Cited by 16
Serum Gamma-Glutamyltransferase Concentration Correlates with Framingham Risk Score in Koreans
Kim, K.-N., Kim, K., Lee, D.-J., & Joo, N. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.10.1305 · Cited by 16
Association between Serum γ-Glutamyltransferase and Chronic Kidney Disease among US Adults
Teppala, S., Shankar, A., Li, J., et al. (2010) · Kidney & Blood Pressure Research · doi:10.1159/000274463 · Cited by 16
Benthem, L., Kuipers, F., Steffens, A. B., & SCHEURINK, A. J. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07804.x · Cited by 16
Coelho‐de‐Souza, A. N., Rocha, M. V. A. P., de Oliveira, K. A., Vasconcelos, Y., dos Santos, E. C., da Silva‐Alves, K. S., Diniz, L. R. L., Ferreira‐da‐Silva, F. W., de Oliveira, A. C., da Ponte, E. L., et al. (2018) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2018.11.005 · Cited by 15
Francois, A., Maumus, S., Vincent‐Viry, M., et al. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.233 · Cited by 15
Lim, J., Kim, Y.-J., Chun, B., et al. (2005) · PubMed · Cited by 15
Influences of pregravid liver enzyme levels on the development of gestational diabetes mellitus
Kim, W. J., Chung, Y., Park, J., et al. (2020) · Liver International · doi:10.1111/liv.14759 · Cited by 14
Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.
Fierbinteanu-Braticevici, C. G., Mohora, M., Tribus, L. C., Petrişor, A., Creţoiu, S. M., Crețoiu, D., Usvat, R., & Ioniţă, L. (2010) · PubMed · Cited by 14
A Longitudinal Genetic Study of Uric Acid and Liver Enzymes in Adolescent Twins
Middelberg, R. P. S., Medland, S. E., Martin, N. G., et al. (2007) · Twin Research and Human Genetics · doi:10.1375/twin.10.5.757 · Cited by 14
“…et al., 2004; Ruttmann et al., 2005; Wannamethee et al., 1995), hypertension (Lee et al., 2003b; Miura et al., 1994) and diabetes (Lee et al., 2003a; Lee et al., 2003b; Lee et al., 2004; Meisinger et al., 2005; Nakanishi et al., 2003; Perry et al., 1998; Wannamethee et al., 2005; Whitfield, 2001).”
Background
Metadata
- Authors
- Perry, I. J., Wannamethee, S. G., & Shaper, A. G.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1998-05-01
- Volume
- 21
- Issue
- 5
- Pages
- 732-737
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2146589543
- Cited by
- 319
- References
- 0
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 2 · 2020: 10 · 2019: 1 · 2018: 8 · 2017: 10 · 2016: 14 · 2015: 5 · 2014: 15 · 2013: 13 · 2012: 18
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- gamma-glutamyl transferase, type 2 diabetes, type 2 diabetes risk, hepatic steatosis, visceral fat, hepatic insulin resistance, biomarkers, alcohol consumption, physical activity, obesity, men
- MeSH terms
- Adult, Alcohol Drinking, Alkaline Phosphatase, Aspartate Aminotransferases, Diabetes Mellitus, Type 2, Follow-Up Studies, gamma-Glutamyltransferase, United Kingdom, Humans, Liver, Male, Middle Aged, Obesity, Predictive Value of Tests, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review